commotio cordis - Parent Heart Watch
... What is Commotio Cordis? • Commotio cordis, Latin for “commotion or disturbance of the heart” is caused by a blunt trauma to the area of the chest directly over the heart during a precise moment of the heart’s cycle, leading to sudden cardiac arrest. Commotio cordis is usually caused by a baseball, ...
... What is Commotio Cordis? • Commotio cordis, Latin for “commotion or disturbance of the heart” is caused by a blunt trauma to the area of the chest directly over the heart during a precise moment of the heart’s cycle, leading to sudden cardiac arrest. Commotio cordis is usually caused by a baseball, ...
Adverse - Research portal
... disease (CAD) [7] and elsewhere [8]. Moreover, in the predrug-eluting stent era the majority of studies on the impact of psychosocial factors on cardiac prognosis have been conducted in post-MI patients. Less emphasis has been given post coronary artery bypass graft surgery (CABG) patients [9] and e ...
... disease (CAD) [7] and elsewhere [8]. Moreover, in the predrug-eluting stent era the majority of studies on the impact of psychosocial factors on cardiac prognosis have been conducted in post-MI patients. Less emphasis has been given post coronary artery bypass graft surgery (CABG) patients [9] and e ...
Preconception Counseling for Women with Congenital Heart Disease
... great arteries or complete transposition of the great arteries after atrial switch operation), pre-existing right ventricle dysfunction may worsen; about 10-20% of these patients have an irreversible ventricular dysfunction after delivery.14,15 The increased cardiac output and reduction in periphera ...
... great arteries or complete transposition of the great arteries after atrial switch operation), pre-existing right ventricle dysfunction may worsen; about 10-20% of these patients have an irreversible ventricular dysfunction after delivery.14,15 The increased cardiac output and reduction in periphera ...
Patients - St. Jude Medical
... including potential clinical successes, anticipated regulatory approvals and future product launches, and projected revenues, margins, earnings, market sizes and market shares. The statements made by the Company are based upon management’s current expectations and are subject to certain risks and un ...
... including potential clinical successes, anticipated regulatory approvals and future product launches, and projected revenues, margins, earnings, market sizes and market shares. The statements made by the Company are based upon management’s current expectations and are subject to certain risks and un ...
Metabolic Cardiology
... provides the missing link in CHF treatment that has been eluding physicians for decades. (Altern Ther Health Med. ...
... provides the missing link in CHF treatment that has been eluding physicians for decades. (Altern Ther Health Med. ...
Anatomy of Pericardium
... inserting the tubes of a coronary bypass machine, and then tightening the ligature, surgeons can stop or divert the circulation of blood in these large arteries while performing cardiac surgery. ...
... inserting the tubes of a coronary bypass machine, and then tightening the ligature, surgeons can stop or divert the circulation of blood in these large arteries while performing cardiac surgery. ...
Ventricular hypertrophy icd 10
... Pulmonary heart disease; Right ventricular hypertrophy: Classification and external resources; Specialty: Pulmonology: ICD-10: I26, I27: ICD-9-CM: 415.0: MedlinePlus What is Concentric left ventricular hypertrophy? I was feeling discomfort and breathlessness after meals and consulted a doctor. He as ...
... Pulmonary heart disease; Right ventricular hypertrophy: Classification and external resources; Specialty: Pulmonology: ICD-10: I26, I27: ICD-9-CM: 415.0: MedlinePlus What is Concentric left ventricular hypertrophy? I was feeling discomfort and breathlessness after meals and consulted a doctor. He as ...
Comorbidity and Ventricular and Vascular Structure and Function in
... generated and age-appropriate allometric powers were compared in community-based cohorts of HFpEF patients (n=386) and age/sex-matched healthy n=193 and hypertensive, n=386 controls. Within HFpEF patients, body size and concomitant comorbidity-adjusted cardiovascular structural and functional parame ...
... generated and age-appropriate allometric powers were compared in community-based cohorts of HFpEF patients (n=386) and age/sex-matched healthy n=193 and hypertensive, n=386 controls. Within HFpEF patients, body size and concomitant comorbidity-adjusted cardiovascular structural and functional parame ...
Sleep and heart failure M.H. Kryger*
... with heart failure, Cheyne-Stokes respiration (CSR) remains something of a physiological and medical enigma. Although there have been hundreds of articles written about Cheyne-Stokes respiration, including many models of respiratory control, it is probably fair to state that we currently do not unde ...
... with heart failure, Cheyne-Stokes respiration (CSR) remains something of a physiological and medical enigma. Although there have been hundreds of articles written about Cheyne-Stokes respiration, including many models of respiratory control, it is probably fair to state that we currently do not unde ...
CardiacDrugs
... • Class III agents slow the repolarization (Phase 3) and prolong the AP and RP in all cardiac tissues. • Amiodarone blocks several channels (e.g., K+ and inactivated Na+ channels) and β-adrenoceptors. - Often effective when other drugs have failed, but should be used sparingly, as it causes serious ...
... • Class III agents slow the repolarization (Phase 3) and prolong the AP and RP in all cardiac tissues. • Amiodarone blocks several channels (e.g., K+ and inactivated Na+ channels) and β-adrenoceptors. - Often effective when other drugs have failed, but should be used sparingly, as it causes serious ...
Severe aortic stenosis in a patient with breast cancer
... Spectrum of flow velocity through the left ventricular outflow tract – pulsed wave Doppler measurement, with the Doppler gate in the left ventricle, ca. 1 cm inferior to the aortic valve. Aortic valve area calculated based on the continuity equation method amounts to 0.76–0.84 cm2, i.e. a value sign ...
... Spectrum of flow velocity through the left ventricular outflow tract – pulsed wave Doppler measurement, with the Doppler gate in the left ventricle, ca. 1 cm inferior to the aortic valve. Aortic valve area calculated based on the continuity equation method amounts to 0.76–0.84 cm2, i.e. a value sign ...
Summary - BidSync
... Establish a relationship with the community center, local health club, or other local qualified individual to offer nutritional, stress management and fitness related classes. ...
... Establish a relationship with the community center, local health club, or other local qualified individual to offer nutritional, stress management and fitness related classes. ...
Untitled - Journal of Postgraduate Medical Institute
... fibrillation and heart failure), associated to other risk factors traditionally linked to bad prognosis (age, LV hypertrophy, LV dysfunction and increased E/e’ ratio) as previously observed.9 In DD, abnormal LV relaxation and reduced LV compliance occur as a consequence of modifications in the inter ...
... fibrillation and heart failure), associated to other risk factors traditionally linked to bad prognosis (age, LV hypertrophy, LV dysfunction and increased E/e’ ratio) as previously observed.9 In DD, abnormal LV relaxation and reduced LV compliance occur as a consequence of modifications in the inter ...
Expository DRAFT
... valves that obstruct the free flow of blood, loose, leaky valves that allow blood to flow the wrong way through the heart, and infected valves” ("Heart Valve Replacement"). If patients have severe valve damage, the valve will need to be replaced, and not repaired (Texas Heart Institute). Replacement ...
... valves that obstruct the free flow of blood, loose, leaky valves that allow blood to flow the wrong way through the heart, and infected valves” ("Heart Valve Replacement"). If patients have severe valve damage, the valve will need to be replaced, and not repaired (Texas Heart Institute). Replacement ...
AHA Scientific Statement
... rates of CHD patients. Meta-analyses based on studies performed in the 1970s and 1980s and reviewed in the 1994 AHA scientific statement on cardiac rehabilitation programs1 and the Agency for Health Care Policy and Research guidelines5 revealed a statistically significant reduction in both cardiac a ...
... rates of CHD patients. Meta-analyses based on studies performed in the 1970s and 1980s and reviewed in the 1994 AHA scientific statement on cardiac rehabilitation programs1 and the Agency for Health Care Policy and Research guidelines5 revealed a statistically significant reduction in both cardiac a ...
Trevor L. Jenkins, MD UH Harrington Heart & Vascular Institute
... describes the palpitations as intermittent “hard” beats that “take her breath away.” Her symptoms are made worse by caffeine consumption. She reports no dizziness or syncope. Medical history is significant for hypertension and hyperlipidemia. Medications are an ACE inhibitor and a statin. • On physi ...
... describes the palpitations as intermittent “hard” beats that “take her breath away.” Her symptoms are made worse by caffeine consumption. She reports no dizziness or syncope. Medical history is significant for hypertension and hyperlipidemia. Medications are an ACE inhibitor and a statin. • On physi ...
In vivo dispersion in repolarization and arrhythmias in - AJP
... panel in Ref. 5). This epicardial value is somewhat higher than that observed in previous studies where it was 14 ms (11) or 41 ms (13) in patients with preserved LV function undergoing bypass surgery. It is suggested that this is due to the underlying cardiomyopathy. In patients with VTs or positiv ...
... panel in Ref. 5). This epicardial value is somewhat higher than that observed in previous studies where it was 14 ms (11) or 41 ms (13) in patients with preserved LV function undergoing bypass surgery. It is suggested that this is due to the underlying cardiomyopathy. In patients with VTs or positiv ...
Syncope and shock
... – Caused by sudden failure of the heart as an effective pump. It occurs most commonly as a complication of acute myocardial infarction, but it may also be seen in patients with severe bradyor tachyarrhythmias, valvular heart disease, or in terminal stage of chronic heart failure (ischemic heart dise ...
... – Caused by sudden failure of the heart as an effective pump. It occurs most commonly as a complication of acute myocardial infarction, but it may also be seen in patients with severe bradyor tachyarrhythmias, valvular heart disease, or in terminal stage of chronic heart failure (ischemic heart dise ...
Electrocardiography_II_Student
... ventricles are larger than normal, causing the impulse to take longer to conduct through the tissue, elongating the QRS complex. In these cases, the QRS might last between 0.9 to 0.12 seconds. Another cause for lengthened QRS complexes are conduction blocks in the Purkinje fibers. As described above ...
... ventricles are larger than normal, causing the impulse to take longer to conduct through the tissue, elongating the QRS complex. In these cases, the QRS might last between 0.9 to 0.12 seconds. Another cause for lengthened QRS complexes are conduction blocks in the Purkinje fibers. As described above ...
8 Prescribing in cardiology Helen Williams •
... disease, diabetes, chronic kidney disease, or the patient is at ⬎20% risk of developing cardiovascular disease. Once drug therapy is initiated, the aim is to lower blood pressure to less than 140/90 mmHg, with more aggressive targets for patients with diabetes (aim for blood pressure ⬍140/80 mmHg or ...
... disease, diabetes, chronic kidney disease, or the patient is at ⬎20% risk of developing cardiovascular disease. Once drug therapy is initiated, the aim is to lower blood pressure to less than 140/90 mmHg, with more aggressive targets for patients with diabetes (aim for blood pressure ⬍140/80 mmHg or ...
Automated external defibrillators: What`s established? What`s new?
... Approximately 1.000 people in the United States suffer from cardiac arrest each day, ...
... Approximately 1.000 people in the United States suffer from cardiac arrest each day, ...
cardiac muscle
... Sinus node has a high velocity of its own depolarization and emits its impulse before A-V node can reach its own threshold for excitation. So sinus node always excites other potentially self-excitatory tissues before their self-excitation can occur. Thus sinus node controls the beat of the heart. ...
... Sinus node has a high velocity of its own depolarization and emits its impulse before A-V node can reach its own threshold for excitation. So sinus node always excites other potentially self-excitatory tissues before their self-excitation can occur. Thus sinus node controls the beat of the heart. ...
AJRCCM 12-29-2014_submitted
... valent conjugate vaccine (5), individuals hospitalized for pneumonia have higher all- ...
... valent conjugate vaccine (5), individuals hospitalized for pneumonia have higher all- ...
1 - Livemedia
... Fayssoil A, et al. Cardiac asynchrony in Duchenne muscular dystrophy. J Clin Monit Comput 2013; 27: 587-589. Yamamoto T, et al. Utility of transmural myocardial strain profile for prediction of early left ventricular dysfunction in patients with Duchenne muscular dystrophy. Am J Cardiol 2013; 111: 9 ...
... Fayssoil A, et al. Cardiac asynchrony in Duchenne muscular dystrophy. J Clin Monit Comput 2013; 27: 587-589. Yamamoto T, et al. Utility of transmural myocardial strain profile for prediction of early left ventricular dysfunction in patients with Duchenne muscular dystrophy. Am J Cardiol 2013; 111: 9 ...
Left ventricular dyssynergy and dispersion as determinant factors of
... Heart failure (HF) patients with severely reduced left ventricular (LV) ejection fraction (EF) are at high risk of fatal ventricular arrhythmias, and their condition is associated with worsening of long-term outcome. Such patients can die suddenly and unpredictably from malignant arrhythmias despite ...
... Heart failure (HF) patients with severely reduced left ventricular (LV) ejection fraction (EF) are at high risk of fatal ventricular arrhythmias, and their condition is associated with worsening of long-term outcome. Such patients can die suddenly and unpredictably from malignant arrhythmias despite ...
Cardiac contractility modulation
.jpg?width=300)
Cardiac contractility modulation (CCM) is a treatment for patients with moderate to severe left ventricular systolic heart failure (NYHA class II–IV). The short- and long-term use of this therapy enhances both the strength of ventricular contraction and the heart’s pumping capacity. The CCM mechanism is based on stimulation of the cardiac muscle by non-excitatory electrical signals (NES). CCM treatment is delivered by a pacemaker-like device that applies the NES, adjusted to and synchronized with the electrical action in the cardiac cycle.In CCM therapy, electrical stimulation is applied to the cardiac muscle during the absolute refractory period. In this phase of the cardiac cycle, electrical signals cannot trigger new cardiac muscle contractions, hence this type of stimulation is known as a non-excitatory stimulation. However, the electrical CCM signals increase the influx of calcium ions into the cardiac muscle cells (cardiomyocytes). In contrast to other electrical stimulation treatments for heart failure, such as pacemaker therapy or implantable cardioverter defibrillators (ICD), CCM does not affect the cardiac rhythm directly. Rather, the aim is to enhance the heart’s natural contraction (the native cardiac contractility) sustainably over long periods of time. Furthermore, unlike most interventions that increase cardiac contractility, CCM is not associated with an unfavorable increase in oxygen demand by the heart (measured in terms of Myocardial Oxygen Consumption or MVO2). This may be explained by the beneficial effect CCM has in improving cardiac efficiency. A meta-analysis in 2014 and an overview of device-based treatment options in heart failure in 2013 concluded that CCM treatment is safe, that it is generally beneficial to patients and that CCM treatment increases the exercise tolerance (ET) and quality of life (QoL) of patients. Furthermore, preliminary long-term survival data shows that CCM is associated with lower long-term mortality in heart failure patients when compared with expected rates among similar patients not treated with CCM.